A bill to establish an annual fee applicable to opioid manufacturers.

United States115th CongressS-3711Senate
Updated: Dec 5, 2018

Summary

Opioid Treatment Surge Act This bill establishes a retroactive annual fee for opioid manufacturers, based on the manufacturer's share of the opioid drug market.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

  1. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate

  2. Introduced in Senate

All available records shown.